Page last updated: 2024-08-23

captopril and sq 28603

captopril has been researched along with sq 28603 in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (88.89)	18.2507
2000's	1 (11.11)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Morphy, R; Rankovic, Z	1
Asaad, M; Rogers, WL; Seymour, AA; Sheldon, JH; Smith, PL	1
Asaad, MM; Fennell, SA; Langenbacher, KM; Lanoce, VM; Rogers, WL; Seymour, AA	1
Bralet, J; Lecomte, JM; Marie, C; Mossiat, C; Schwartz, JC	1
Allen, GT; Powell, JR; Tesfamariam, B	1
Abboa-Offei, BE; Asaad, MM; Dorso, CR; Rogers, WL; Seymour, AA; Smith, PL	1
D'Orléans-Juste, P; Fournier, A; Lebel, N; Sirois, P	1
Chakir, M; D'Orléans-Juste, P; Plante, GE	1
Abboa-Offei, BE; Asaad, MM; Mathers, PD; Seymour, AA; Weber, H	1

Reviews

1 review(s) available for captopril and sq 28603

Article	Year
Designed multiple ligands. An emerging drug discovery paradigm. Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors	2005

Article

Year

Designed multiple ligands. An emerging drug discovery paradigm.

Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors

2005

Other Studies

8 other study(ies) available for captopril and sq 28603

Article	Year
Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1 Topics: Alanine; Anesthesia; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Cyclic GMP; Dogs; Drug Synergism; Female; Kidney; Male; Natriuresis; Neprilysin; Renal Circulation; Vascular Resistance; Vasodilation	1994
Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2 Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Captopril; Cardiac Pacing, Artificial; Cyclic GMP; Dogs; Female; Heart Failure; Hemodynamics; Kidney; Male; Neprilysin; Renin	1993
Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction. The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:3 Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart; Hemodynamics; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Wistar	1995
Bradykinin B2 receptor-mediated chronotropic effect of bradykinin in isolated guinea pig atria. European journal of pharmacology, 1995, Jul-25, Volume: 281, Issue:1 Topics: Adrenergic beta-Agonists; Alanine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Function; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Enzyme Inhibitors; Guinea Pigs; Heart; Heart Atria; Heart Rate; In Vitro Techniques; Kallidin; Male; Myocardium; Nitric Oxide; Prostaglandins; Receptor, Bradykinin B2; Receptors, Bradykinin; Sensitivity and Specificity	1995
Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:2 Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Female; Humans; Kidney; Macaca fascicularis; Neprilysin; Peptide Fragments	1996
Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma. British journal of pharmacology, 1996, Volume: 117, Issue:1 Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelin-1; Endothelins; Glycopeptides; Guinea Pigs; Histamine; In Vitro Techniques; Lung; Neprilysin; Protease Inhibitors; Protein Precursors; Thiorphan	1996
Neutral endopeptidase inhibition, a new approach in the exploration of diabetic vasculopathy in rats. European journal of pharmacology, 1995, Oct-04, Volume: 285, Issue:1 Topics: Alanine; Animals; Blood Pressure; Capillary Permeability; Captopril; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Female; Glycopeptides; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Streptozocin; Thiorphan	1995
Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors. Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:3 Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cyclic GMP; Enzyme Inhibitors; Female; Kidney; Macaca fascicularis; Natriuretic Peptide, C-Type; Neprilysin; Proteins; Sodium	1996